Search results for "Red blood cell"

showing 10 items of 125 documents

Erythrocyte deformability in macrocytosis determined by means of ektacytometry techniques

2010

There is little information regarding the behaviour of red blood cell deformability in macrocytosis. We have determined in 114 patients with macrocytosis (MCV > 97 fL) and in 115 age and sex-matched subjects with normocytosis (VCM < 97 fL) erythrocyte deformability by means of ektacytometric techniques (Rheodyn SSD) measuring the erythrocyte elongation index (EEI) at 12, 30 and 60 Pa. Patients with macrocytosis showed statistically higher EEI at all the shear stresses tested when compared with controls (p < 0.001). When patients with macrocytosis were classified according to their main diagnosis as hepatic or renal disease, HIV and miscellaneous, 66.7%, 41.7%, 36.7% and 33.3% of patients, r…

AdultMalemedicine.medical_specialtyPhysiologyBilirubinAnemiaHuman immunodeficiency virus (HIV)NormocytosisMacrocytosismedicine.disease_causeGastroenterologychemistry.chemical_compoundErythrocyte DeformabilityPhysiology (medical)Internal medicinemedicineHumansErythrocyte deformabilityAnemia MacrocyticAlanine aminotransferaseAgedbusiness.industryHematologyMiddle Agedmedicine.diseaseRed blood cellmedicine.anatomical_structurechemistryImmunologyFemaleStress MechanicalCardiology and Cardiovascular MedicinebusinessClinical Hemorheology and Microcirculation
researchProduct

Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassemia major patients: a randomised clinical trial

2009

A multicentre randomized open-label trial was designed to assess the effectiveness of long-term sequential deferiprone–deferoxamine (DFO–DFP) versus DFP alone to treat thalassaemia major (TM). DFP at 75 mg/kg, divided into three oral daily doses, for 4 d/week and DFO by subcutaneous infusion (8–12 h) at 50 mg/kg per day for the remaining 3 d/week was compared with DFP alone at 75 mg/kg, administered 7 d/week during a 5-year follow-up. The main outcome measures were differences between multiple observations of serum ferritin concentrations. Secondary outcomes were survival analysis, adverse events, and costs. Consecutive thalassaemia patients (275) were assessed for eligibility; 213 of these…

AdultMalemedicine.medical_specialtyRandomizationAdolescentPyridonesAdministration OralKaplan-Meier EstimateDeferoxamineInfusions SubcutaneousIron Chelating AgentsGastroenterologylaw.inventionYoung Adultchemistry.chemical_compoundRandomized controlled triallawInternal medicinemedicineHumansDeferiproneAdverse effectDecreased serum ferritinSurvival analysisbusiness.industryHematologySurgeryClinical trialDeferoxamineChelation thalassaemia clinical trials red blood cell disorders iron overload.Treatment OutcomechemistryFerritinsThalassemiaDrug Therapy CombinationFemalebusinessDeferiproneFollow-Up Studiesmedicine.drug
researchProduct

6-thioguanosine diphosphate and triphosphate levels in red blood cells and response to azathioprine therapy in Crohn's disease.

2005

Background & Aims: Azathioprine is the gold standard for immunosuppressive therapy in Crohn's disease (CD) and its molecular mechanism of action is caused by the metabolite 6-thioguanosine triphosphate (TGTP). In this study we assessed the impact of TGTP levels for monitoring of azathioprine therapy. Methods: A novel, highly sensitive assay was established to measure levels of TGTP and its precursors 6-thioguanosine monophosphates and 6-thioguanosine diphosphates (TGDP) in red blood cells from 50 CD patients. The results were correlated with clinical outcome. Results: TGTP levels could be quantified in 47 patients and a subgroup of these patients showed significantly high levels of TGDP. 6-…

Adultmedicine.medical_specialtyErythrocytesMetaboliteAzathioprineInflammatory bowel diseaseGastroenterologyGuanosine Diphosphatechemistry.chemical_compoundCrohn DiseaseInternal medicineAzathioprinemedicineHumansCrohn's diseaseHepatologyThiopurine methyltransferasebiologybusiness.industryGastroenterologyAzathioprine therapyAntibodies MonoclonalThionucleotidesmedicine.diseaseInfliximabGuanine NucleotidesInfliximabRed blood cellmedicine.anatomical_structurechemistryImmunologybiology.proteinbusinessBiomarkersImmunosuppressive Agentsmedicine.drugClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
researchProduct

Foetal erythrocytes exhibit an increased ability to scavenge for nitric oxide

1998

The presence of adult human whole blood inhibited in vitro relaxations of rat aortic rings by the nitric oxide (NO) donor S-nitroso-N-acetyl-DL-penicillamine (SNAP). Incubation with foetal blood containing the same concentration of haemoglobin produced a shift to the right of the relaxation curve. SNAP-induced vasorelaxations were more inhibited by dialysed solutions of haemoglobin than by the presence of erythrocytes in the organ bath, but there were no differences between the effect of adult or foetal haemoglobins. The presence of plasma from adult or foetal blood did not modify the effects of SNAP. Relaxations induced by endogenous, endothelium-derived, NO were more inhibited by foetal t…

Adultmedicine.medical_specialtyErythrocyteshaemoglobin foetalVasodilationIn Vitro TechniquesNitric OxideNitric oxidechemistry.chemical_compoundnewbornInternal medicinemedicineAnimalsHumansnitric oxide (NO)Aortavascular responseWhole bloodPharmacologyDose-Response Relationship DrugPenicillamineSnapAnatomyFetal BloodRatsRed blood cellEndocrinologymedicine.anatomical_structurechemistryVasoconstrictionCirculatory systemembryonic structuresHemoglobinerythrocyteBlood vessel
researchProduct

The impact of del Nido cardioplegia solution on blood morphology parameters

2021

Background: Crystalloid cardioplegic solutions are believed to reduce hemoglobin significantly and increase the transfusion rate. However, recent reports indicate that the del Nido cardioplegia may preserve blood morphology parameters. Methods: In “The del Nido versus cold blood cardioplegia in aortic valve Replacement” trial patients undergoing aortic valve replacement were randomized into the del Nido (DN) or cold blood cardioplegia (CB) group. For the subanalysis, patients who underwent blood transfusions were excluded from the study. Red blood cell (RBC) count, hemoglobin, white blood cell (WBC) count and platelet (PLT) count were measured before the surgery, 24-, 48-, and 96 hours post…

Advanced and Specialized Nursingmedicine.diagnostic_testbusiness.industryGeneral Medicinemedicine.diseaseRed blood cellmedicine.anatomical_structureAortic valve replacementBlood productAnesthesiaWhite blood cellCoagulopathyMedicineRadiology Nuclear Medicine and imagingPlateletHemoglobinCardiology and Cardiovascular MedicinebusinessSafety ResearchPartial thromboplastin timePerfusion
researchProduct

Lidocaine inhibits potassium efflux and hemolysis in erythrocytes during oxidative stress in vitro.

2000

Lidocaine is a widely used local anesthetic agent. The aim of this work was to study the action of lidocaine on human red blood cells exposed to an oxidative stress in vitro. Blood was obtained from healthy volunteers. After separation from plasma, the erythrocytes were suspended in phosphate buffer. Oxidative stress was induced by incubation with a free radical generator, the 2,2' azobis (2-amidinopropane) hydrochloride (AAPH). Erythrocytes were incubated with or without lidocaine at two concentrations (36.93 and 73.85 microM) and with or without AAPH (20 mM). Electron paramagnetic resonance (EPR) spectroscopy was performed to identify the free radical species generated by AAPH using the s…

AntioxidantErythrocytesOxygen radical absorbance capacityLidocaineRadicalPotassiummedicine.medical_treatmentAmidineschemistry.chemical_elementIn Vitro Techniquesmedicine.disease_causeHemolysisAntioxidantsmedicineHumansAnesthetics LocalPharmacologyChromatographyElectron Spin Resonance SpectroscopyLidocaineBiological Transportmedicine.diseaseOxidantsHemolysisRed blood cellOxidative Stressmedicine.anatomical_structureBiochemistrychemistryPotassiumOxidative stressmedicine.drugGeneral pharmacology
researchProduct

Melatonin protects human red blood cells from oxidative hemolysis: new insights into the radical-scavenging activity.

1999

Antioxidant activity of melatonin in human erythrocytes, exposed to oxidative stress by cumene hydroperoxide (cumOOH), was investigated. CumOOH at 300 microM progressively oxidized a 1% suspension of red blood cells (RBCs), leading to 100% hemolysis in 180 min. Malondialdehyde and protein carbonyls in the membrane showed a progressive increase, as a result of the oxidative damage to membrane lipids and proteins, reaching peak values after 30 and 40 min, respectively. The membrane antioxidant vitamin E and the cytosolic reduced glutathione (GSH) were totally depleted in 20 min. As a consequence of the irreversible oxidative damage to hemoglobin (Hb), hemin accumulated into the RBC membrane d…

AntioxidantLysisErythrocytesmedicine.medical_treatmentIn Vitro Techniquesmedicine.disease_causeHemolysisMelatoninchemistry.chemical_compoundEndocrinologymedicineBenzene DerivativesHumansDimethyl SulfoxideMannitolMelatoninChemistryHydroxyl RadicalErythrocyte MembraneGlutathioneFree Radical ScavengersMalondialdehydeGlutathioneRed blood cellOsmotic FragilityOxidative Stressmedicine.anatomical_structureBiochemistryHeminHydroxyl radicalLipid PeroxidationOxidative stressmedicine.drugJournal of pineal research
researchProduct

Determination of lectin-cell-binding parameters by a new agglutination technique.

1992

We applied a recently described technique which is based on a light transmission/scattering method to determine the association characteristics of the Geodia lectin to sheep erythrocytes. The agglutination assays were performed in a total volume of 3 ml with 5.4 x 10(6) erythrocytes/ml. At a concentration of 360 ng/ml 50% of the lectin molecules were bound to the cells within the first 10 s of incubation. Scatchard analyses revealed an association constant (K(a)) of 0.9 +/- 0.1 x 10(8) M-1 and a number of 3.8 +/- 0.6 x 10(6) lectin binding sites on one erythrocyte. The method was also successfully applied to determine quantitatively the inhibitory potential of sugars competing with cell sur…

BiochemistryAgglutination techniquechemistry.chemical_compoundLectinsmedicineAnimalsLactoseIncubationchemistry.chemical_classificationScatchard plotChromatographySheepbiologyChemistryLectinHemagglutination TestsHemagglutination Inhibition TestsPoriferaRed blood cellAgglutination (biology)Kineticsmedicine.anatomical_structureReceptors MitogenImmunologyCalibrationbiology.proteinGlycoproteinProtein BindingBiological chemistry Hoppe-Seyler
researchProduct

Glutathione metabolism in type 2 diabetes and its relationship with microvascular complications and glycemia

2018

Aims/hypotheses We hypothesized that there is decreased synthesis of glutathione (GSH) in type 2 diabetes (T2DM) especially in the presence of microvascular complications, and this is dependent on the degree of hyperglycemia. Methods In this case-control study, we recruited 16 patients with T2DM (7 without and 9 with microvascular complications), and 8 age- and sex-matched non-diabetic controls. We measured GSH synthesis rate using an infusion of [2H2]-glycine as isotopic tracer and collection of blood samples for liquid chromatography mass spectrometric analysis. Results Compared to the controls, T2DM patients had lower erythrocyte GSH concentrations (0.90 ± 0.42 vs. 0.35 ± 0.30 mmol/L; P …

Blood GlucoseMale0301 basic medicinelcsh:MedicineType 2 diabetesmedicine.disease_causeBiochemistrychemistry.chemical_compoundEndocrinology0302 clinical medicineGlucose MetabolismAnimal CellsRed Blood CellsMedicine and Health SciencesDiabetes diagnosis and managementMedicineAmino Acidslcsh:ScienceMultidisciplinaryOrganic CompoundsMiddle AgedGlutathioneMass spectrometricType 2 DiabetesChemistryPhysical SciencesCarbohydrate MetabolismFemaleCellular TypesResearch ArticleAdultGlutathione metabolismmedicine.medical_specialtyHbA1cEndocrine DisordersGlycine030209 endocrinology & metabolism03 medical and health sciencesDiabetes mellitusInternal medicineMoleDiabetes MellitusHumansHemoglobinBlood Cellsbusiness.industrylcsh:ROrganic ChemistryChemical CompoundsCase-control studyBiology and Life SciencesProteinsCell BiologyGlutathionemedicine.diseaseDiagnostic medicineOxidative StressMetabolism030104 developmental biologyEndocrinologyAliphatic Amino AcidsDiabetes Mellitus Type 2chemistryMetabolic DisordersCase-Control StudiesMicrovesselslcsh:QPeptidesbusinessDiabetic AngiopathiesOxidative stressPLOS ONE
researchProduct

Fructose-enriched diet modifies antioxidant status and lipid metabolism in spontaneously hypertensive rats

2005

Abstract Objective High-fructose consumption in industrial countries has been shown to induce metabolic abnormalities or syndrome X. Changes in antioxidant defense are unknown in hypertension associated with metabolic disorders induced by high-fructose feeding. Methods Twenty spontaneously hypertensive rats were assigned to one of two groups; one received a fructose-enriched diet (60% fructose) and the other a starch diet. After a 13-wk diet period, total antioxidant status was assessed in the blood and liver by monitoring the rate of free radical-induced red blood cell hemolysis. Antioxidants (enzymes and vitamins) were determined in blood and liver. Gene expression of antioxidant enzymes …

Blood GlucoseMalemedicine.medical_specialtyErythrocytesAntioxidantEndocrinology Diabetes and Metabolismmedicine.medical_treatmentalpha-TocopherolGene ExpressionAscorbic AcidFructoseThiobarbituric Acid Reactive SubstancesAntioxidantsLipid peroxidationSuperoxide dismutasechemistry.chemical_compoundRats Inbred SHRInternal medicinemedicineAnimalsInsulinRNA MessengerVitamin Achemistry.chemical_classificationGlutathione PeroxidaseNutrition and DieteticsbiologySuperoxide DismutaseGlutathione peroxidaseStarchFructoseLipid MetabolismAscorbic acidDietRatsRed blood cellEndocrinologymedicine.anatomical_structureLiverchemistryHypertensionbiology.proteinLipid PeroxidationPeroxidaseNutrition
researchProduct